Evidence map›Paper›PMID 30972567›Full record

ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2019

En bloc spondylectomy in patients older than 60 years: indications, results and complications in a series of 37 patients.

Carmine Zoccali, Gennaro Scotto, Luca Cannavò, Jacopo Baldi, Ulrica Scaffidi-Argentina, Alessandro Luzzati

Abstract read
PubMed Publisher
In one paragraph

Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. En bloc resection in patients younger than 16 years affected by primary spine tumors: indications, results and complications in a series of 22 patients.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020
    Review
  6. Revision surgery for tumors of the thoracic and lumbar spine: causes, prevention, and treatment strategy.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carmine ZoccaliOncological Orthopaedics, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. carminezoccali@libero.it.ORCID 0000-0001-8847-6772
Gennaro ScottoOncological Orthopedics and Reconstructive Surgery, IRCCS - Galeazzi Orthopedic Institute, Milan, Italy.
Luca CannavòOncological Orthopedics and Reconstructive Surgery, IRCCS - Galeazzi Orthopedic Institute, Milan, Italy.
Jacopo BaldiOncological Orthopaedics, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Ulrica Scaffidi-ArgentinaOncological Orthopaedics, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Alessandro LuzzatiOncological Orthopedics and Reconstructive Surgery, IRCCS - Galeazzi Orthopedic Institute, Milan, Italy.
Istituto Ortopedico Galeazzi · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITNational Cancer Institute · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review a series of patients > 60 years affected by primary spine bone tumors, who have undergone surgery, and to describe their clinical presentation, results and complications associated with surgical treatment.

methodsA review of all patients > 60 years affected by primary spine bone tumor surgically treated with en bloc spondylectomy from 1993 to 2015 was performed. Thirty-seven cases were identified, and clinical and radiological characteristics, therapy, complications and survival were evaluated.

resultsOnly 14/37 cases were not previously treated. Complications were quite frequent: 64% of patients experienced almost one early complication; 48% and 27% experienced 2 and ≥ 3 early complications, respectively; 37% of patients experienced almost one late complication; and 10% and 8% experienced 2 and ≥ 3 late complications, respectively. Massive blood loss and dural tear were the more frequent surgical complications; no deaths were reported during surgeries; one patient died during the first postoperative day due to hemorrhage and cardiac complications, one during the third postoperative day for the same cause despite of a savage surgery, and another one died at 7 days from index surgery due to myocardial infarction. The 5-year disease-related survival and global survival were 62.8% and 52.1%, respectively. Nineteen patients are still alive, 15 of whom without any evidence of disease.

conclusionsPrimary malignant or locally aggressive bone tumors of the spine should be treated with wide surgery also in the older age, although the complications rate and the risk of patient survival can be considered high. These slides can be retrieved under Electronic Supplementary Material.

Indexed as

AgedAged, 80 and overAllograftsAngiographyBack PainBlood Loss, SurgicalChemotherapy, AdjuvantDura MaterFemaleHumansIntraoperative ComplicationsMaleMiddle AgedNeoadjuvant TherapyNeurosurgical ProceduresOperative TimeEn bloc spondylectomyOlder ageSpine surgerySpine tumorWide surgery

Identifiers

PMID30972567
OpenAlexW2939864248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.